Bharti Airtel, Adani Green Energy, Adani Ports & Special Economic Zone, Ambuja Cements, Hero MotoCorp, Astral, NHPC Ltd. Gujarat Fluorochemicals Ltd. Deepak Nitrite Ltd. Phoenix Mills Ltd. Aditya Birla Fashion and Retail Ltd. Motherson Sumi Wiring India Ltd. GlaxoSmithKline Pharmaceuticals, Navin Fluorine International, Bayer Cropscience, Bharat Dynamics, Ramco Cements, and other domestic companies are set to declare the earnings on Tuesday

“Indian shares opened lower on Friday, dragged by losses across most sectors, on recession fears in the US and hawkish commentary by major central banks, following their US counterpart. US retail sales in November fell more than expected, suggesting higher borrowing costs and fears of an imminent recession are hurting household spending in the world's largest economy,” Mohit Nigam, Fund Manager & Head, Hem Securities, said.

State Bank of India said its board has approved Rs 10,000 crore capital raising plan through Tier I bonds. The fund raising through Additional Tier 1 capital up to an amount of Rs 10,000 crore is subject to approval from the government.

Deepak Jasani, Retail Research-Head, HDFC Securities, said, “Nifty rose for the fourth consecutive session on November 1. Nifty opened gap up and remained in a 104 point band through the day. At close, Nifty was up 0.74% or 133.2 points at 18145.4. Among sectors, power, IT and healthcare indices rose the most while Bank index fell marginally. Midcap Index outperformed rising 1.04% while Smallcap index rose just 0.26%.”

Soriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures - in October 2012, following a stint at pharma peer Roche. With the Frenchman at the helm, the fortunes of the Anglo-Swedish drugmaker changed dramatically.

Soriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures - in October 2012, following a stint at pharma peer Roche.

Novavax's protein-based vaccine was approved for emergency use by the US Food and Drug Administration (USFDA) last month in India.

The Drugs Controller General of India (DCGI) has approved Lynparza (Olaparib) as a monotherapy for the treatment of adult patients with early breast cancer, who have previously been treated with neoadjuvant or adjuvant chemotherapy.

A trial dubbed AMEERA-5, which was testing amcenestrant on women with newly-diagnosed advanced breast cancer, was stopped early because an independent monitoring panel found no signs of it working. "All other studies of amcenestrant, including in early-stage breast cancer (AMEERA-6), will be discontinued," Sanofi said.

SII Chief Executive Officer Adar Poonawalla told NDTV that the vaccine is being developed in collaboration with Novavax. Poonawalla further said that the vaccine will be specific to the BA5 sub-variant of Omicron.

The representatives of Organisation of Pharmaceutical Producers of India (OPPI), which represents multinational pharma companies and domestic pharma representatives that run PAP programmes, will meet minister of health and family Mansukh Mandaviya and officials from department of pharmaceutical (DoP), National Pharmaceutical Pricing Authority (NPPA) on Monday to discuss the issue regarding TMR on PAP drugs.

Net profit slumped 64 percent to $746 million compared with the first six months of last year, AstraZeneca said in a statement. Operating expenses jumped 33 percent, "reflecting the addition of Alexion, and continued investment in new launches and the pipeline" of drugs, the group said.

The researchers used records on 1,951,866 (19.5 lakh) and 3,219,349 (32 lakh) adults who had received two doses of Pfizer and AstraZeneca vaccnes, respectively and 2,422,980 (24 lakh) unvaccinated adults.

The Goodall doll, which Mattel says will be partly made with recycled plastic.

"India is an incredible rising power in Asia, with one of the fastest growing economies in the world - already worth GBP 2.25 trillion - and set to be the world's third largest economy by 2050. India is also our biggest partner in the Indo-Pacific, which is increasingly the geopolitical centre of the world, with two-thirds of humanity, and a third of the global economy - and that share is rising every year," Johnson said, during his India visit.

Vakrangee, GM Breweries, Mysore Paper Mills, GG Automotive Gears and Sri Krishna Constructions are among companies that will announce their quarterly earnings today.

Giridhara Babu, senior epidemiologist said it is time to revise and ensure that every eligible person gets a booster shot if not got already. "Similar to UK policy, all the persons aged 18 years and over can be offered a booster dose of coronavirus (Covid-19) vaccine."

Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said the short-term trend of the Nifty seems to have reversed down from the highs and the current chart pattern indicates the possibility of further weakness in the short term. One may expect Nifty to slide down to 15,600-15,500 levels again in the near term, he said.

"Sanofi-GSK's vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial in an environment of high Omicron variant circulation," Sanofi said in a statement. Sanofi's Paris-listed shares and GSK's London-listed shares were both up more than 1% in morning trading.

Monkeypox was given its name because it was first discovered in a group of macaques in 1958

A friendlier way to take a vaccine, the inhaled form requires much less vaccine - as little as one per cent of what is currently being used in the present vaccines.

Welspun Corp is in strong bullish momentum where it took support in the cluster of 50 and 20-DMA after a pullback and now it is resuming its bullish momentum.

India's most valued stock Reliance Industries has added Rs 1.67 lakh crore to its m-cap to Rs 17.91 lakh crore (Monday's intraday levels) from Rs 16.24 lakh crore as of May 12.

Nasal vaccines are administered, as the name suggests, through the nose.

Many participants at this year's event, which ends on Thursday, have welcomed occasional sunshine, alpine spring flowers and screeching swifts circling overhead as a welcome change from sub-zero temperatures and perilous icy sidewalks. Others have missed the winter wonderland atmosphere.

At least two stocks will go ex-dividend today. That includes ITC, which had announced a final dividend of Rs 6.25 per share recently. Visaka Industries, which announced a final dividend of Rs 8 per share, will also go ex-dividend today.

The MACD showed bearish signs on the counters of Atul, Avanti Feeds, Chalet Hotels, Godfrey Phillips, Ircon International and MOIL. A bearish crossover on the MACD on these counters indicated that they had just begun their downward journey.

The CanSino vaccine uses a harmless virus called an adenovirus to deliver the spike protein of the coronavirus into the body, which then prompts an immune response. The technology is similar to vaccines made by Johnson and Johnson and AstraZeneca, which use different adenoviruses.

Companies on top of the hiring action include Amex, Bank of America, Wells Fargo, Citi, Barclays, Morgan Stanley, HSBC, Standard Chartered, Goldman Sachs, Amazon, Target, Walmart, Shell, GSK, Abbott, Pfizer, J&J, Novartis, and AstraZeneca, among others, according to Xpheno data.

Momentum on vaccinations and treatments has faded even as new, more infectious variants rise and billions across the globe remain unprotected. Congress has refused to meet Biden's request to provide another $22.5 billion in what he has called critically needed aid funding.

The findings, published in The Lancet Infectious Disease journal, show that fourth dose mRNA booster vaccines for COVID-19 are well-tolerated in people who received Pfizer as a third dose. They are also effective at increasing both antibody and cellular immunity up to and above baseline and peak levels observed following third dose boosters, according to the researchers.

Poonawalla said he even looked at diluting a stake in Serum from private equity to raise the capital but they didn't need to do it because they went to other countries and philanthropists instead who understood the urgent need of doing it.

International data available on booster doses of AstraZeneca and Covishield suggests a three- to four-fold increase in antibody levels after their administration, Pawar said in a written reply.

The collaboration between Wockhardt UK and Serum Life Sciences UK Ltd will help create a considerable number of employment opportunities along with the creation of a new sterile fill and finish facility in Wrexham, North Wales.

Quality can be defined differently by many analysts, but there is a consensus that a company that uses its capital efficiently and churns good profits for its shareholders consistently can be regarded as a quality name.

The company's shot, called Corbevax, is the third vaccine approved for use in children aged 12 and above in India, joining Zydus Cadila's DNA shot ZyCoV-D and homegrown player Bharat Biotech's Covaxin. India has so far only started vaccinating children aged 15 and above. According to government figures, more than 76 million children between 15 and 17 have been inoculated mainly using Covaxin.

The lab tests also showed that some antibodies have entirely lost their ability to neutralise Omicron at realistic dosages. "The bottom line is we have countermeasures to treat Omicron. That's good news," said study lead author Yoshihiro Kawaoka, from the University of Wisconsin-Madison in the US.

"We are in discussion with (Bharat Biotech) as we consider the overall needs of the COVAX portfolio in 2022. However, we have no agreement for supply of Covaxin to COVAX at this time," the spokesperson said in an email.